Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis

Nephrology

Volumn 15, Issue 4, 2010, Pages 482-490

  Ayodele, Olugbenga Edward ^a   Okpechi, Ikechi G ^a   Swanepoel, Charles R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Lupus nephritis; Predictors; Renal outcome

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; REMISSION; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION; BIOPSY; BLOOD; CHI SQUARE DISTRIBUTION; COMPLICATION; DISEASE COURSE; GLOMERULUS FILTRATION RATE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MORTALITY; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT; KAPLAN-MEIER ESTIMATE;

EID: 77952894902     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01290.x     Document Type: Article

References (32)

1. Mok CC, Tang SSK. Incidence and risk factors of renal disease in Chinese patients with systemic lupus erythematosus. Am. J. Med. 2004 17 : 791 795.
2. Waldman W, Appel GB. Update in the treatment of lupus nephritis. Kidney Int 2006 70 : 1403 1412.
3. Korbet SM, Schwartz MM, Lewis EJ, for the Collaborative Study Group. Severe lupus nephritis: Racial differences in presentation and outcome. J. Am. Soc. Nephrol. 2007 18 : 244 254.
4. Austin HA 3rd., Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int. 1994 45 : 544 550.
5. Mok CC, Wong RWS, Lau CS. Lupus nephritis in Southern Chinese patients: Clinicopathologic findings and long term outcome. Am. J. Kidney Dis. 1999 34 : 315 323.
6. MacGowan JR, Ellis S, Griffiths M, Isenberg DA. Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1997 and 1999. Rheumatology 2002 41 : 981 987.
7. Mok CC. Prognostic factors in lupus nephritis. Lupus 2005 14 : 39 44.
8. Mok CC, Ho CT, Chan KW, Lau CS, Wong RW. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum. 2002 46 : 1003 1013.
9. Korbet SM, Lewis EJ, Schwartz MM et al. for the Lupus Nephritis Collaborative Study Group. Factors predictive of outcome in severe lupus nephritis. Am. J. Kidney Dis. 2000 35 : 904 914.
10. Contreras G, Pardo V, Cely C et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus 2005 14 : 890 895.
11. Barr RG, Seliger S, Gerald B et al. Prognosis in proliferative lupus nephritis: The role for socio-economic status and race/ethnicity. Nephrol. Dial. Transplant. 2003 18 : 2039 2046.
12. De Castro WP, Morales JV, Wagner MB, Graudenz M, Edelweiss MI, Gonçalves LF. Hypertension and Afro-descendant ethnicity: A bad interaction for lupus nephritis treated with cyclophosphamide? Lupus 2007 16 : 724 730.
13. Cortés-Hermández J, Ordi-Ros J, Labrador M et al. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus 2003 12 : 287 296.
14. Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol. Dial. Transplant. 2007 22 : 2531 2539.
15. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C. 'Nephritic flares' are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int. 1996 50 : 2047 2053.
16. Mok CC, Lau CS, Chan TM, Wong RWS. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999 8 : 188 196.
17. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology Response Criteria for Proliferative and Membranous Renal Disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006 54 : 421 432.
18. Moroni G, Ventura D, Riva P et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am. J. Kidney Dis. 2004 43 : 28 36.
19. Seedat YK, Parag KB, Ramsaroop R. Systemic lupus erythematosus and renal involvement: A South African experience. Nephron 1994 66 : 426 430.
20. Wadee S, Tikly M, Hopley M. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology 2007 46 : 1487 1491.
21. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 25 : 1271 1277.
22. Mansia G, De Backer G, Dominiczak A et al. 2007 European Society of Cardiology and European Society of Hypertension Guidelines for the management of arterial hypertension. J. Hypertens. 2007 25 : 1105 1187.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease; evaluation, classification and stratification. Am. J. Kidney Dis. 2002 39 (2 Suppl 1 S1 266.
24. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Disease.
25. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 2000 284 : 3043 3045.
26. Klag MJ, Whelton PK, Randall BL et al. A prospective study of blood pressure and the incidence of end-stage renal disease in 332 544 men. N. Engl. J. Med. 1996 334 : 43 8.
27. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360 : 1903 1913.
28. Bono L, Cameron JS, Hicks JA. The very long term prognosis and complications of lupus nephritis and its treatment. Q. J. Med. 1999 92 : 211 218.
29. Coovadia H, Jewkes R, Barron P, Sanders D, Mcintyre D. The health and health system of South Africa: Historical roots of current public health challenges. Lancet 2009 374 : 817 834.
30. Manzi S, Meilahn EN, Rairie J et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am. J. Epidemiol. 1997 145 : 408 415.
31. Roldan CA. Valvular and coronary heart disease in systemic inflammatory diseases. Heart 2008 94 : 1089 1001.
32. Weening JJ, D'Agati VD, Schwartz MM et al. on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus nephritis re-visited. J. Am. Soc. Nephrol. 2004 15 : 241 250 (Erratum: J Am Soc Nephrol 2004; 15: 835-836).